Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients

BACKGROUND: The purpose of this phase II study was to evaluate the safety and efficacy of weekly irinotecan and capecitabine (wXELIRI) treatment in patients with metastatic colorectal cancer, specifically the rate of severe diarrhea. METHODS: Patients with unresectable histologically confirmed metas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Li, Wenhua, Xu, Jianming, Shen, Lin, Liu, Tianshu, Guo, Weijian, Zhang, Wen, Chen, Zhiyu, Zhu, Xiaodong, Li, Jin
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300831/
https://ncbi.nlm.nih.gov/pubmed/25527007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-986
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky